China Official Says Taking Steps To Expand Availability Of Key Drugs
This article was originally published in PharmAsia News
China's vice premier said steps would be taken beginning as early as this year to reform the nation's healthcare system, including the availability and handling of medicines. Vice Premier Li Keqiang said at a meeting on the subject that one intent is to ensure affordable access to crucial drugs, beginning this year in government hospitals and clinics at the grassroots level. He said the government also plans to separate treatment services from medicine sales in government hospitals in 16 cities this year and to increase reimbursements for medical treatments for severe diseases. (Click here for more)
You may also be interested in...
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.
Perrigo will launch generics of GSK's OTC Voltaren Arthritis Pain drug later in 2020 following FDA approval of its ANDA. GSK, which received FDA's OTC switch approval in February, still hasn't launched the product or indicated when it will.
Kline & Company’s worst-case scenario – which it says is looking more and more likely – has the US cosmetics and personal-care market declining by as much as 8.1% in 2020. However, Kline, Mintel and other market intelligence firms say there are opportunities available to companies struggling to weather the COVID-19 storm.